Optimizerx Corp (OPRX)

$10.92 +0.16 (1.49%)
Market Cap 200.58M
Revenue (ttm) 92.13M
Net Income (ttm) -18.66M
EPS (ttm) N/A
PE Ratio 27.05
Forward PE 25.92
Profit Margin -20.25%
Debt to Equity Ratio 0.23
Volume 266,700
Avg Vol 252,838
Day's Range N/A - N/A
Shares Out 18.64M
Stochastic %K 29%
Beta 1.09
Analysts Strong Sell
Price Target $24.33

Company Profile

OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awa...

Industry: Health Information Services
Sector: Healthcare
Phone: 248 651 6568
Address:
260 Charles Street, Suite 302, Waltham, United States
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 30 at 2:13 AM
$OPRX RSI: 27.48, MACD: -0.6536 Vol: 0.88, MA20: 12.43, MA50: 13.28 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
HappyStockholder
HappyStockholder Jan. 21 at 8:30 PM
$OPRX The recent price action here makes no sense. It would seem we are due for a bounce.
0 · Reply
ItMeYaBoiGoose
ItMeYaBoiGoose Jan. 17 at 1:00 AM
$OPRX
1 · Reply
Knot2
Knot2 Jan. 13 at 2:32 PM
$OPRX here’s a freebie for the low life scrapers that follow me…this has a run in it!
2 · Reply
ItMeYaBoiGoose
ItMeYaBoiGoose Jan. 5 at 3:44 PM
$OPRX tell nobody about this except your best friends.
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 5 at 11:32 AM
$OPRX RSI: 29.41, MACD: -0.8157 Vol: 0.72, MA20: 13.24, MA50: 15.48 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
KingdomKing
KingdomKing Dec. 25 at 12:17 PM
$OPRX A transition phase is underway where operating consistency matters more than rapid expansion. Cash generation and unit economics need to converge with strategy for the thesis to mature. Any disconnect between guidance and results will be magnified by sentiment. Future re‑rating depends on tightening the gap between narrative and reality.
1 · Reply
tilance
tilance Dec. 24 at 4:13 PM
$OPRX opened a position here today...
1 · Reply
SuperGreenToday
SuperGreenToday Dec. 17 at 1:57 PM
$OPRX Share Price: $12.77 Contract Selected: Mar 20, 2026 $10 Calls Buy Zone: $8.45 – $10.44 Target Zone: $15.57 – $19.03 Potential Upside: 74% ROI Time to Expiration: 92 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
HappyStockholder
HappyStockholder Dec. 2 at 4:22 PM
$OPRX Is this the deadest board on Stocktwits?
2 · Reply
Latest News on OPRX
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing

Jan 7, 2026, 8:00 AM EST - 26 days ago

OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing

OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story

Dec 23, 2025, 10:03 AM EST - 5 weeks ago

OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story

OptimizeRx Continues Expansion of the Company's Point-Of-Care Network

Dec 17, 2025, 4:30 AM EST - 6 weeks ago

OptimizeRx Continues Expansion of the Company's Point-Of-Care Network

OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript

Nov 7, 2025, 5:56 AM EST - 3 months ago

OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript

OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance

Nov 6, 2025, 4:01 PM EST - 3 months ago

OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance

OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET

Oct 20, 2025, 8:00 AM EDT - 3 months ago

OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET

4 Top AI-Powered Healthcare Stocks

Oct 9, 2025, 5:00 AM EDT - 4 months ago

4 Top AI-Powered Healthcare Stocks

BSX VEEV ZEPP

OptimizeRx: How The Stock Is Changing Pharma Marketing

Oct 7, 2025, 10:02 PM EDT - 4 months ago

OptimizeRx: How The Stock Is Changing Pharma Marketing

OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference

Sep 10, 2025, 7:30 AM EDT - 5 months ago

OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference

OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising

Sep 9, 2025, 4:05 PM EDT - 5 months ago

OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising

OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth

Aug 19, 2025, 7:30 AM EDT - 5 months ago

OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth

OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:26 PM EDT - 6 months ago

OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript

OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

Aug 7, 2025, 4:01 PM EDT - 6 months ago

OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

OptimizeRx: Stock Could Rise As Profitability Is Achieved

Jul 18, 2025, 3:47 PM EDT - 7 months ago

OptimizeRx: Stock Could Rise As Profitability Is Achieved

OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET

Jul 17, 2025, 7:30 AM EDT - 7 months ago

OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET

OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors

Jun 24, 2025, 7:30 AM EDT - 7 months ago

OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors

Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions

Jun 18, 2025, 3:00 AM EDT - 8 months ago

Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions

OptimizeRx to Participate in Upcoming Investor Conferences

May 16, 2025, 7:30 AM EDT - 9 months ago

OptimizeRx to Participate in Upcoming Investor Conferences

OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript

May 12, 2025, 9:56 PM EDT - 9 months ago

OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript

OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

May 12, 2025, 4:05 PM EDT - 9 months ago

OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report

May 1, 2025, 4:05 PM EDT - 9 months ago

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report

OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET

Apr 23, 2025, 7:30 AM EDT - 10 months ago

OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment

Apr 18, 2025, 4:15 PM EDT - 10 months ago

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment

OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million

Mar 12, 2025, 11:56 AM EDT - 11 months ago

OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million

OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 11:04 AM EDT - 11 months ago

OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript

OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results

Mar 12, 2025, 7:30 AM EDT - 11 months ago

OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results

OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations

Mar 11, 2025, 7:30 AM EDT - 11 months ago

OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations

OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer

Mar 10, 2025, 7:30 AM EDT - 11 months ago

OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer

OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET

Feb 27, 2025, 7:30 AM EST - 1 year ago

OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET

OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO

Dec 23, 2024, 8:45 AM EST - 1 year ago

OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO

OptimizeRx Corporation (OPRX) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 10:58 PM EST - 1 year ago

OptimizeRx Corporation (OPRX) Q3 2024 Earnings Call Transcript

OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET

Oct 31, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET

OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value

Sep 10, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value

OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences

Sep 9, 2024, 12:00 PM EDT - 1 year ago

OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences

OptimizeRx Corporation (OPRX) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 8:06 PM EDT - 1 year ago

OptimizeRx Corporation (OPRX) Q2 2024 Earnings Call Transcript

OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET

Jul 25, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET

OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation

Jul 23, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation

OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients

Jul 15, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients

New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations

Jun 20, 2024, 7:30 AM EDT - 1 year ago

New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations

OptimizeRx Corporation (OPRX) Q1 2024 Earnings Call Transcript

May 14, 2024, 11:21 PM EDT - 1 year ago

OptimizeRx Corporation (OPRX) Q1 2024 Earnings Call Transcript

OptimizeRx Reports First Quarter 2024 Financial Results

May 14, 2024, 4:01 PM EDT - 1 year ago

OptimizeRx Reports First Quarter 2024 Financial Results

OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET

Apr 26, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET

OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report

Apr 18, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report

OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results

Apr 16, 2024, 7:00 AM EDT - 1 year ago

OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results

OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row

Apr 11, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row

OptimizeRx Corporation (OPRX) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 11:20 AM EDT - 2 years ago

OptimizeRx Corporation (OPRX) Q4 2023 Earnings Call Transcript

OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET

Mar 25, 2024, 7:30 AM EDT - 2 years ago

OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET

OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023

Mar 11, 2024, 4:30 PM EDT - 2 years ago

OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023

OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community' Outreach Effort

Mar 4, 2024, 3:51 PM EST - 2 years ago

OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community' Outreach Effort

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

Jan 25, 2024, 7:30 AM EST - 2 years ago

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 30 at 2:13 AM
$OPRX RSI: 27.48, MACD: -0.6536 Vol: 0.88, MA20: 12.43, MA50: 13.28 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
HappyStockholder
HappyStockholder Jan. 21 at 8:30 PM
$OPRX The recent price action here makes no sense. It would seem we are due for a bounce.
0 · Reply
ItMeYaBoiGoose
ItMeYaBoiGoose Jan. 17 at 1:00 AM
$OPRX
1 · Reply
Knot2
Knot2 Jan. 13 at 2:32 PM
$OPRX here’s a freebie for the low life scrapers that follow me…this has a run in it!
2 · Reply
ItMeYaBoiGoose
ItMeYaBoiGoose Jan. 5 at 3:44 PM
$OPRX tell nobody about this except your best friends.
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 5 at 11:32 AM
$OPRX RSI: 29.41, MACD: -0.8157 Vol: 0.72, MA20: 13.24, MA50: 15.48 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
KingdomKing
KingdomKing Dec. 25 at 12:17 PM
$OPRX A transition phase is underway where operating consistency matters more than rapid expansion. Cash generation and unit economics need to converge with strategy for the thesis to mature. Any disconnect between guidance and results will be magnified by sentiment. Future re‑rating depends on tightening the gap between narrative and reality.
1 · Reply
tilance
tilance Dec. 24 at 4:13 PM
$OPRX opened a position here today...
1 · Reply
SuperGreenToday
SuperGreenToday Dec. 17 at 1:57 PM
$OPRX Share Price: $12.77 Contract Selected: Mar 20, 2026 $10 Calls Buy Zone: $8.45 – $10.44 Target Zone: $15.57 – $19.03 Potential Upside: 74% ROI Time to Expiration: 92 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
HappyStockholder
HappyStockholder Dec. 2 at 4:22 PM
$OPRX Is this the deadest board on Stocktwits?
2 · Reply
HappyStockholder
HappyStockholder Nov. 18 at 7:32 PM
$OPRX I know the market has gone sour, but OPRX started going down before that, and seems to be picking up speed. Buying opportunity or falling knife?
0 · Reply
JarvisFlow
JarvisFlow Nov. 17 at 12:55 PM
Stephens & Co. has adjusted their stance on OptimizeRx ( $OPRX ), setting the rating to Equal-Weight with a target price of 20 → 17.
0 · Reply
HappyStockholder
HappyStockholder Nov. 12 at 12:53 PM
$OPRX Strange price action since stellar earnings results, raised outlook, and several analyst price target increases. I have taken this opportunity to open an investment here.
0 · Reply
sofocles
sofocles Nov. 7 at 3:02 PM
$OPRX GREAT QUARTER RESULTS. JUST A MATTER OF TIME FOR RECOVERY
0 · Reply
DARKP00L
DARKP00L Nov. 7 at 2:24 PM
$OPRX 09:07 on Nov. 07 2025 Citizens Maintains Market Outperform on OptimizeRx, Raises Price Target to $24 #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 1:59 PM
Citizens has updated their rating for OptimizeRx ( $OPRX ) to Market Outperform with a price target of 24.
0 · Reply
Doozio
Doozio Oct. 26 at 9:23 PM
$OPRX MLYS gonna become BILI’s before 🐒🍌🧠⏰♾️ ends?
0 · Reply
sofocles
sofocles Oct. 24 at 5:35 PM
$OPRX any news here?
0 · Reply
MaverikIT
MaverikIT Oct. 14 at 8:51 PM
$OPRX - trying to break out
0 · Reply
WrappedLunatic
WrappedLunatic Oct. 7 at 12:41 AM
$OPRX yikes
0 · Reply
LayerOne
LayerOne Oct. 5 at 3:52 PM
$OPRX Healthcare technology. Testing key support. Volume pattern shows distribution. Growth concerns persisting.
0 · Reply